Project documents | Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410] | Guidance | NICE

Documents

A list of downloadable documents created during development.

Invitation to participate

Final scope ^{PDF 163 KB} 07 February 2023
Final stakeholder list ^{PDF 198 KB} 07 February 2023
NICE's response to comments on the draft scope and provisional stakeholder list ^{PDF 354 KB} 07 February 2023

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral ^{PDF 170 KB} 23 November 2022
Draft matrix of consultees and commentators post referral ^{PDF 197 KB} 23 November 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral ^{PDF 178 KB} 21 June 2021
Draft matrix of consultees and commentators post referral ^{PDF 196 KB} 21 June 2021

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral ^{PDF 347 KB} 02 October 2018
Draft matrix pre referral ^{PDF 251 KB} 02 October 2018